[123i]-Mibg Curium Netherlands

Iodine (123I) Iobenguane is a radiopharmaceutical used in diagnostic imaging for neuroendocrine tumors and other conditions. It is administered intravenously and detected via gamma camera imaging. This product is supplied by Curium Netherlands B.V. and is intended for medical use only.

Iodine (123I) Iobenguane is primarily used in nuclear medicine imaging to detect neuroendocrine tumors, such as pheochromocytomas and neuroblastomas. It may also be used in evaluating other conditions involving abnormal catecholamine metabolism. This radiopharmaceutical helps healthcare providers visualize specific tissues or abnormalities in the body.

Following intravenous administration, Iodine (123I) Iobenguane is taken up by tissues with high catecholamine activity, such as the adrenal medulla and certain tumors. The radioactive signal emitted allows for detailed imaging of these areas using specialized equipment. Patients may experience mild discomfort at the injection site, but the effects are generally transient.

This radiopharmaceutical should only be handled and administered by trained medical professionals in a controlled clinical setting. Patients should inform their healthcare provider of any allergies, especially to iodine or previous contrast agents. Pregnant or breastfeeding individuals should avoid exposure due to potential risks to the fetus or infant.

Certain medications, such as tricyclic antidepressants, sympathomimetics, or other drugs affecting catecholamine metabolism, may interfere with the uptake of Iodine (123I) Iobenguane. Alcohol and other substances should be avoided as directed by a healthcare provider. Patients should disclose all current medications to their doctor before this procedure.